Dallas Mavericks forward Anthony Davis is confronting a possible season-ending hand injury that may necessitate surgery, drastically altering the team’s plans as the NBA trade deadline approaches. The injury occurred during a crucial moment in Thursday’s narrow 116-114 defeat to the Utah Jazz, where Davis, while defending against Lauri Markkanen’s drive, sustained ligament damage in his left hand with just under three minutes left in the game.
Following the incident, an MRI on Friday revealed the extent of the damage, prompting Davis to seek additional medical opinions to decide on the best course of action. Sources indicate that if surgery is chosen, recovery could span several months, potentially sidelining him for the remainder of the season. Even a non-surgical route would require at least six weeks of rehabilitation, significantly impacting the Mavericks’ lineup.
This setback arrives at a pivotal time for Dallas, which has been actively exploring trade options for Davis ahead of the February 5 deadline. The 10-time All-Star, acquired in the high-profile swap that sent Luka Dončić to the Lakers, has been a focal point in trade talks, but his latest injury complicates negotiations and could reduce his value on the market.
Davis’s stint with the Mavericks has been plagued by health issues since his arrival in early 2025. In limited appearances over two seasons, he has dealt with multiple injuries, including abdominal and calf strains, casting doubt on his long-term reliability and affecting team dynamics.
Financially, Davis carries a substantial contract, with earnings of $54.1 million this season and future commitments that include $58.5 million next year and a player option for $62.8 million in 2027-28. These financial obligations, coupled with his injury-prone history, pose significant challenges for Dallas in any trade scenario.
Amidst a rebuilding phase, the Mavericks had hoped to utilize Davis’s talents to either compete or secure assets through a trade. His absence creates a gap in their frontcourt, potentially derailing their playoff hopes and forcing a reevaluation of roster strategy.
Looking ahead, the outcomes of Davis’s medical consultations will guide the next steps. If surgery is deemed necessary, the Mavericks might shift their trade deadline focus to other players or accept lower returns. The situation remains fluid, with the team and its supporters awaiting further developments as the deadline looms.
